In addition, upregulation of CD88 has also been observed in numerous neurodegenerative diseases in rodents [34-37], including ALS [10,11], so it is plausible to propose that the complement system could be involved in the pathophysiology of ALS. Here, C5AR1 is linked to neurodegenerative disease.